NASDAQ · ATTO
Attovia Therapeutics, Inc.
$15.27-$0.53 (-3.35%)
Attovia Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.46% below the high.
Loading market information…
NASDAQ · KWE · USD
Stock price, earnings
Quote as of Jun 27, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
KWESST Micro Systems Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow KWESST Micro Systems Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
KWESST Micro Systems Inc. focuses on creating and bringing to market advanced tactical equipment and ammunition. The company serves various clients, including armed forces, public safety organizations, and individuals seeking personal defense solutions. Its product lineup includes a range of less-lethal options, such as its PARA OPS devices and ARWEN product lines. Founded in 2017, KWESST Micro Systems Inc. operates from its headquarters in Ottawa, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2024 | Jan 17, 2024 | -$37.82+66.02% vs estimate | $446.99K+51.81% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$15.27-$0.53 (-3.35%)
Attovia Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.46% below the high.
$0.05$0.00 (0.0%)
Lilium N.V.’s quoted price sits in the lower half of its reported 52-week range, 27.37% below the high.
$0.54-$0.01 (-2.0%)
Astra Space, Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.64% below the high.
$0.21+$0.01 (+5.14%)
Ault Alliance, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.17% below the high.
$10.00+$2.30 (+29.87%)
CEA Industries Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.43% below the high.
$0.37+$0.06 (+19.35%)
Capstone Green Energy Corporation’s quoted price sits in the lower half of its reported 52-week range, 83.7% below the high.
$1.08+$1.08 (+100.0%)
ENGlobal Corporation’s quoted price sits in the lower half of its reported 52-week range, 15.62% below the high.
$2.45+$2.45 (+100.0%)
Nxu, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.56% below the high.
